NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/03/2023
Back to search
Official data from USPTO
IMMUNOMET
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
10/03/2023
Trademark type
Word
Nice classes
42
Filing date
02/28/2020
Registration date
10/03/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/03/2023
Last transaction
10/03/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2015-07-00
First use in commerce
2015-07-00
Drawing code
4
Owner type
03
Owner location
Houston, TX
Examiner
WITKOWSKI, RYAN MICHAEL
Law office
M80
Current location
PETITIONS OFFICE
Holders and representatives
Holders
ImmunoMet Therapeutics Inc.
Representatives
Christiane S. Campbell DUANE MORRIS LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Pharmaceutical research and development
Publications
History of USPTO decisions and trademark events.
36 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
10/03/2023
CORV
REVIEW OF CORRESPONDENCE COMPLETE
09/14/2023
APET
ASSIGNED TO PETITION STAFF
09/14/2023
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
08/29/2023
IUCN
NOTICE OF ALLOWANCE CANCELLED
08/22/2023
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
08/22/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/23/2023
EX5G
SOU EXTENSION 5 GRANTED
02/22/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/22/2023
EXT5
SOU EXTENSION 5 FILED
02/06/2023
EEXT
SOU TEAS EXTENSION RECEIVED
02/06/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/24/2022
EX4G
SOU EXTENSION 4 GRANTED
08/22/2022
EXT4
SOU EXTENSION 4 FILED
08/22/2022
EEXT
SOU TEAS EXTENSION RECEIVED
08/22/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/24/2022
EX3G
SOU EXTENSION 3 GRANTED
02/22/2022
EXT3
SOU EXTENSION 3 FILED
02/22/2022
EEXT
SOU TEAS EXTENSION RECEIVED
02/22/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/21/2021
EX2G
SOU EXTENSION 2 GRANTED
08/19/2021
EXT2
SOU EXTENSION 2 FILED
08/19/2021
EEXT
SOU TEAS EXTENSION RECEIVED
08/19/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/27/2021
EX1G
SOU EXTENSION 1 GRANTED
02/25/2021
EXT1
SOU EXTENSION 1 FILED
02/25/2021
EEXT
SOU TEAS EXTENSION RECEIVED
02/25/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
08/25/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/30/2020
PUBO
PUBLISHED FOR OPPOSITION
06/30/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/10/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/24/2020
DOCK
ASSIGNED TO EXAMINER
05/19/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/06/2020
NWAP
NEW APPLICATION ENTERED
03/05/2020
Continuous trademark protection
Get notified about every new filing that threatens IMMUNOMET or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.